**Core Concept**
Glycoprotein IIb/IIIa receptor antagonists are a class of antiplatelet medications that inhibit the activation of platelets by blocking the glycoprotein IIb/IIIa receptor, thereby preventing platelet aggregation. This receptor plays a crucial role in the final common pathway of platelet aggregation, where fibrinogen binds to the glycoprotein IIb/IIIa receptor, cross-linking platelets and forming a platelet plug.

**Why the Correct Answer is Right**
Glycoprotein IIb/IIIa receptor antagonists work by binding to the glycoprotein IIb/IIIa receptor on the surface of platelets, preventing the receptor from binding to fibrinogen and thereby inhibiting platelet aggregation. This is particularly useful in the treatment and prevention of acute coronary syndromes, such as myocardial infarction and unstable angina. Examples of glycoprotein IIb/IIIa receptor antagonists include abciximab, eptifibatide, and tirofiban.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because glycoprotein IIb/IIIa receptor antagonists are not a type of anticoagulant. While both antiplatelet and anticoagulant medications are used to prevent thrombosis, they work through different mechanisms.

**Option B:** This option is incorrect because glycoprotein IIb/IIIa receptor antagonists are not a type of vasodilator. While vasodilators are used to treat conditions such as hypertension and angina, glycoprotein IIb/IIIa receptor antagonists work by inhibiting platelet aggregation rather than dilating blood vessels.

**Option C:** This option is incorrect because glycoprotein IIb/IIIa receptor antagonists are not a type of antiarrhythmic medication. While antiarrhythmic medications are used to treat conditions such as atrial fibrillation and ventricular tachycardia, glycoprotein IIb/IIIa receptor antagonists work by inhibiting platelet aggregation rather than regulating heart rhythm.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that glycoprotein IIb/IIIa receptor antagonists are a type of antiplatelet medication that should be used in conjunction with other antiplatelet agents, such as aspirin, and anticoagulants, such as heparin, to prevent thrombosis in patients with acute coronary syndromes.

**Correct Answer:** C.